Publications:

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.

Nature Communications

Vandekerkhove, Gillian G; Lavoie, Jean-Michel JM; Annala, Matti M; Murtha, Andrew J AJ; Sundahl, Nora N; Walz, Simon S; Sano, Takeshi T; Taavitsainen, Sinja S; Ritch, Elie E; Fazli, Ladan L; Hurtado-Coll, Antonio A; Wang, Gang G; Nykter, Matti M; Black, Peter C PC; Todenhöfer, Tilman T; Ost, Piet P; Gibb, Ewan A EA; Chi, Kim N KN; Eigl, Bernhard J BJ; Wyatt, Alexander W AW

Publication Date: 2021-01-08

Variant appearance in text: ERBB2: R98Q

PubMed Link: 33420073

Variant Present in the following documents:

• 41467_2020_20493_MOESM3_ESM.xlsx, sheet 4

View BVdb publication page

NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma.

Oncotarget

Tiedje, Vera V; Ting, Saskia S; Herold, Thomas T; Synoracki, Sarah S; Latteyer, Soeren S; Moeller, Lars C LC; Zwanziger, Denise D; Stuschke, Martin M; Fuehrer, Dagmar D; Schmid, Kurt Werner KW

Publication Date: 2017-06-27

Variant appearance in text: ERBB2: R98Q

PubMed Link: 28489587

Variant Present in the following documents:

• Main text
• oncotarget-08-42613.pdf

View BVdb publication page